Back to results
TerminatedPhase 3

A Long Term Study of ALKS 5461 in the Treatment of Refractory Major Depressive Disorder (MDD)

NCT03610048

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Alkermes Investigational Site

Tucson, Arizona, United States

+33 additional locations

View on ClinicalTrials.gov
A Long Term Study of ALKS 5461 in the Treatment of Refractory Major Depressive Disorder (MDD) — TrialFind